US Stock MarketDetailed Quotes

Ultragenyx Pharmaceutical (RARE)

Watchlist
  • 24.100
  • -0.180-0.74%
Close Apr 24 15:59 ET
  • 23.840
  • -0.260-1.08%
Post 17:55 ET
2.37BMarket Cap-4.13P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ultragenyx Pharmaceutical (RARE) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
20.18%673M
25.89%207.28M
14.65%159.93M
13.24%166.5M
27.99%139.29M
29.03%560M
29.50%164.65M
42.27%139.49M
35.75%147.03M
8.30%108.83M
Operating revenue
20.18%673M
25.89%207.28M
14.65%159.93M
13.24%166.5M
27.99%139.29M
29.03%560M
29.50%164.65M
42.27%139.49M
35.75%147.03M
8.30%108.83M
Cost of revenue
41.56%109M
70.95%29.35M
33.16%27.99M
8.09%23M
63.47%28.66M
71.11%77M
44.96%17.17M
91.33%21.02M
114.65%21.28M
43.04%17.53M
Gross profit
16.77%564M
20.65%177.93M
11.37%131.94M
14.11%143.49M
21.17%110.63M
24.16%483M
27.91%147.48M
36.07%118.47M
27.80%125.75M
3.47%91.3M
Operating expense
7.85%1.1B
7.94%291.22M
20.91%302.83M
3.83%251.38M
-1.20%253.57M
6.37%1.02B
13.77%269.79M
7.88%250.46M
-1.72%242.11M
5.90%256.65M
Selling and administrative expenses
8.72%349M
7.39%87.94M
7.80%86.62M
7.50%86.65M
12.33%87.8M
3.55%321M
6.30%81.89M
7.25%80.35M
-0.98%80.6M
1.98%78.16M
Research and development costs
7.45%750M
8.18%203.28M
27.10%216.21M
2.00%164.74M
-7.12%165.77M
7.72%698M
17.36%187.9M
8.18%170.11M
-2.09%161.5M
7.72%178.49M
Operating profit
0.19%-535M
7.38%-113.28M
-29.47%-170.89M
7.28%-107.89M
13.55%-142.94M
5.80%-536M
-0.38%-122.31M
9.04%-131.99M
21.35%-116.36M
-7.30%-165.35M
Net non-operating interest income expense
-42.31%-37M
-138.31%-12.96M
-66.33%-8.29M
3.65%-8.25M
-6.95%-7.51M
33.33%-26M
35.73%-5.44M
57.73%-4.98M
9.05%-8.56M
24.86%-7.02M
Non-operating interest income
-32.43%25M
-35.17%6.51M
-45.36%5.86M
-21.71%5.79M
-22.59%6.83M
37.04%37M
13.30%10.04M
82.47%10.73M
24.09%7.4M
40.29%8.82M
Non-operating interest expense
-1.59%62M
25.76%19.47M
-9.95%14.15M
-12.02%14.04M
-9.50%14.34M
-4.55%63M
-10.64%15.48M
-11.06%15.71M
3.80%15.96M
1.35%15.85M
Other net income (expense)
120.00%1M
71.51%-1.45M
-109.72%-365K
136.62%2.13M
-68.24%680K
-400.00%-5M
-276.74%-5.08M
277.29%3.76M
-236.81%-5.82M
8,334.62%2.14M
Gain on sale of security
----
----
0.00%678K
99.77%-9K
-104.19%-157K
-380.86%-1.12M
-181.95%-1.55M
147.78%678K
-1,629.12%-3.99M
1,221.56%3.75M
Other non- operating income (expenses)
120.00%1M
79.88%-934K
-133.90%-1.04M
217.00%2.14M
152.15%837K
-400.00%-5M
-436.45%-4.64M
540.20%3.08M
8.04%-1.83M
-621.10%-1.61M
Income before tax
-0.71%-571M
3.86%-127.69M
-34.78%-179.54M
12.80%-114M
12.02%-149.77M
6.90%-567M
-4.23%-132.82M
16.22%-133.21M
17.82%-130.74M
-4.13%-170.23M
Income tax
100.00%4M
126.56%870K
188.12%873K
10.37%947K
187.91%1.31M
200.00%2M
109.90%384K
-53.38%303K
17.21%858K
-8.08%455K
Net income
-1.05%-575M
3.49%-128.56M
-35.12%-180.41M
12.65%-114.95M
11.49%-151.08M
6.26%-569M
-7.81%-133.2M
16.37%-133.52M
17.66%-131.6M
-4.09%-170.68M
Net income continuous Operations
-1.05%-575M
3.49%-128.56M
-35.12%-180.41M
12.65%-114.95M
11.49%-151.08M
6.26%-569M
-7.81%-133.2M
16.37%-133.52M
17.66%-131.6M
-4.09%-170.68M
Minority interest income
Net income attributable to the parent company
-1.05%-575M
3.49%-128.56M
-35.12%-180.41M
12.65%-114.95M
11.49%-151.08M
6.26%-569M
-7.81%-133.2M
16.37%-133.52M
17.66%-131.6M
-4.09%-170.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-1.05%-575M
3.49%-128.56M
-35.12%-180.41M
12.65%-114.95M
11.49%-151.08M
6.26%-569M
-7.81%-133.2M
16.37%-133.52M
17.66%-131.6M
-4.09%-170.68M
Basic earnings per share
7.31%-5.83
7.19%-1.29
-29.29%-1.81
23.03%-1.17
22.66%-1.57
23.76%-6.29
8.55%-1.39
37.22%-1.4
32.44%-1.52
12.88%-2.03
Diluted earnings per share
7.31%-5.83
7.19%-1.29
-29.29%-1.81
23.03%-1.17
22.66%-1.57
23.76%-6.29
8.55%-1.39
37.22%-1.4
32.44%-1.52
12.88%-2.03
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 20.18%673M25.89%207.28M14.65%159.93M13.24%166.5M27.99%139.29M29.03%560M29.50%164.65M42.27%139.49M35.75%147.03M8.30%108.83M
Operating revenue 20.18%673M25.89%207.28M14.65%159.93M13.24%166.5M27.99%139.29M29.03%560M29.50%164.65M42.27%139.49M35.75%147.03M8.30%108.83M
Cost of revenue 41.56%109M70.95%29.35M33.16%27.99M8.09%23M63.47%28.66M71.11%77M44.96%17.17M91.33%21.02M114.65%21.28M43.04%17.53M
Gross profit 16.77%564M20.65%177.93M11.37%131.94M14.11%143.49M21.17%110.63M24.16%483M27.91%147.48M36.07%118.47M27.80%125.75M3.47%91.3M
Operating expense 7.85%1.1B7.94%291.22M20.91%302.83M3.83%251.38M-1.20%253.57M6.37%1.02B13.77%269.79M7.88%250.46M-1.72%242.11M5.90%256.65M
Selling and administrative expenses 8.72%349M7.39%87.94M7.80%86.62M7.50%86.65M12.33%87.8M3.55%321M6.30%81.89M7.25%80.35M-0.98%80.6M1.98%78.16M
Research and development costs 7.45%750M8.18%203.28M27.10%216.21M2.00%164.74M-7.12%165.77M7.72%698M17.36%187.9M8.18%170.11M-2.09%161.5M7.72%178.49M
Operating profit 0.19%-535M7.38%-113.28M-29.47%-170.89M7.28%-107.89M13.55%-142.94M5.80%-536M-0.38%-122.31M9.04%-131.99M21.35%-116.36M-7.30%-165.35M
Net non-operating interest income expense -42.31%-37M-138.31%-12.96M-66.33%-8.29M3.65%-8.25M-6.95%-7.51M33.33%-26M35.73%-5.44M57.73%-4.98M9.05%-8.56M24.86%-7.02M
Non-operating interest income -32.43%25M-35.17%6.51M-45.36%5.86M-21.71%5.79M-22.59%6.83M37.04%37M13.30%10.04M82.47%10.73M24.09%7.4M40.29%8.82M
Non-operating interest expense -1.59%62M25.76%19.47M-9.95%14.15M-12.02%14.04M-9.50%14.34M-4.55%63M-10.64%15.48M-11.06%15.71M3.80%15.96M1.35%15.85M
Other net income (expense) 120.00%1M71.51%-1.45M-109.72%-365K136.62%2.13M-68.24%680K-400.00%-5M-276.74%-5.08M277.29%3.76M-236.81%-5.82M8,334.62%2.14M
Gain on sale of security --------0.00%678K99.77%-9K-104.19%-157K-380.86%-1.12M-181.95%-1.55M147.78%678K-1,629.12%-3.99M1,221.56%3.75M
Other non- operating income (expenses) 120.00%1M79.88%-934K-133.90%-1.04M217.00%2.14M152.15%837K-400.00%-5M-436.45%-4.64M540.20%3.08M8.04%-1.83M-621.10%-1.61M
Income before tax -0.71%-571M3.86%-127.69M-34.78%-179.54M12.80%-114M12.02%-149.77M6.90%-567M-4.23%-132.82M16.22%-133.21M17.82%-130.74M-4.13%-170.23M
Income tax 100.00%4M126.56%870K188.12%873K10.37%947K187.91%1.31M200.00%2M109.90%384K-53.38%303K17.21%858K-8.08%455K
Net income -1.05%-575M3.49%-128.56M-35.12%-180.41M12.65%-114.95M11.49%-151.08M6.26%-569M-7.81%-133.2M16.37%-133.52M17.66%-131.6M-4.09%-170.68M
Net income continuous Operations -1.05%-575M3.49%-128.56M-35.12%-180.41M12.65%-114.95M11.49%-151.08M6.26%-569M-7.81%-133.2M16.37%-133.52M17.66%-131.6M-4.09%-170.68M
Minority interest income
Net income attributable to the parent company -1.05%-575M3.49%-128.56M-35.12%-180.41M12.65%-114.95M11.49%-151.08M6.26%-569M-7.81%-133.2M16.37%-133.52M17.66%-131.6M-4.09%-170.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -1.05%-575M3.49%-128.56M-35.12%-180.41M12.65%-114.95M11.49%-151.08M6.26%-569M-7.81%-133.2M16.37%-133.52M17.66%-131.6M-4.09%-170.68M
Basic earnings per share 7.31%-5.837.19%-1.29-29.29%-1.8123.03%-1.1722.66%-1.5723.76%-6.298.55%-1.3937.22%-1.432.44%-1.5212.88%-2.03
Diluted earnings per share 7.31%-5.837.19%-1.29-29.29%-1.8123.03%-1.1722.66%-1.5723.76%-6.298.55%-1.3937.22%-1.432.44%-1.5212.88%-2.03
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -